Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 33, Issue 7, 1999, Pages 2044-2051

  Olivotto, Iacopo ^a   Maron, Barry J ^b   Montereggi, Alessio ^a   Mazzuoli, Francesco ^a   Dolara, Alberto ^a   Cecchi, Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE;

EID: 0032745561     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00094-7     Document Type: Article

References (41)

1. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-9, 844-52.
2. McKenna W., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy role of age and clinical, electrocardiographic and hemodynamic features . Am J Cardiol. 47:1981;532-538.
3. Frank S., Braunwald E. Idiopathic hypertrophic subaortic stenosis clinical analysis of 126 patients with emphasis on the natural history . Circulation. 37:1968;759-788.
4. Wigle E.D., Sasson Z., Henderson M.A., et al. Hypertrophic cardiomyopathy the importance of the site and the extent of hypertrophy: a review . Prog Cardiovasc Dis. 28:1985;1-83.
5. Wigle E.D., Rakowski H., Kimball B.P., Williams W.G. Hypertrophic cardiomyopathy clinical spectrum and treatment . Circulation. 92:1995;1680.
6. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med. 336:1997;775-785.
7. Maron B.J. Hypertrophic cardiomyopathy. Lancet. 350:1997;127-133.
8. Marian A.J., Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 92:1995;1336-1347.
9. Schwartz K., Carrier L., Guicheney P., Komajda M. Molecular basis of familial cardiomyopathies. Circulation. 91:1995;532-540.
10. Watkins H., McKenna W.J., Thierfelder L., et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 332:1995;1058-1064.
11. Louie E.K., Edwards L.C. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 36:1994;275-308.
12. Spirito P., Chiarella F., Carratino L., Berisso M.Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 320:1989;749-755.
13. Kofflard M.J., Waldstein D.J., Vos J., ten Cate F.J. Prognosis in hypertrophic cardiomyopathy long-term follow-up in a large, unselected outpatient population . Am J Cardiol. 72:1993;939-943.
14. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., Maron B.J. Hypertrophic cardiomyopathy in Tuscany clinical course and outcome in an unselected population . J Am Coll Cardiol. 26:1995;1529-1536.
15. Shapiro L.M., Zezulka A. Hypertrophic cardiomyopathy a common disease with a good prognosis - five year experience of a district general hospital . Br Heart J. 50:1983;530-533.
16. Cannan C.R., Reeder G.S., Bailey K.R., Melton L.J. III, Gersh B.J. Natural history of hypertrophic cardiomyopathy a population-based study, 1976 through 1990 . Circulation. 92:1995;2488-2495.
17. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999;281:650-5.
18. Maron B.J., Roberts W.C., Epstein S.E. Sudden death in hypertrophic cardiomyopathy profile of 78 patients . Circulation. 65:1982;1388-1394.
19. Swan D.A., Bell B., Oakley C., Goodwin J. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J. 33:1971;671-685.
20. Watkins H., Rosenzweig A., Hwang D.-S., et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 326:1992;1108-1114.
21. Anan R., Greve G., Thierfelder L., et al. Prognostic implication of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest. 93:1994;280-285.
22. McKenna W.J., Camm A.J. Sudden death in hypertrophic cardiomyopathy assessment of patients at high risk . Circulation. 80:1989;1489-1492.
23. Maron B.J., Cecchi F., McKenna W.J. Risk factors and current status of risk stratification profiles for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J. 72:(Suppl):1994;S14-S18.
24. Sadoul N., Prasad K., Elliot P.M., Bannerjee S., Frenneaux M.P., McKenna W.J. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation. 96:1997;2987-2991.
25. McKenna W.J., England D., Doi Y.L., Deanfield J.E., Oakley C.M., Goodwin J.F. Arrhythmia in hypertrophic cardiomyopathy: I. Influence on prognosis. Br Heart J. 46:1981;168-172.
26. Cecchi F., Maron B.J., Epstein S.E. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol. 13:1989;1283-1288.
27. Edwards R.H.T., Krisinsson A., Warrel D.A., Goodwin J.F. Effects of propranolol on response to exercise in hypertrophic cardiomyopathy. Br Heart J. 32:1970;219-225.
28. Frenneaux M.P., Counihan P.J., Caforio A.L.P., Chikamori T., McKenna W.J. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation. 82:1991;1995-2002.
29. Maron B.J., Spirito P. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol. 72:1993;970-972.
30. Maron B.J., Epstein S.E. Hypertrophic cardiomyopathy a discussion of nomenclature . Am J Cardiol. 43:1979;1242-1244.
31. Maron B.J., Nichols P.F., Pickle L.W., Wesley Y.E., Mulvihill J.J. Patterns of inheritance in hypertrophic cardiomyopathy assessment by M-mode and two-dimensional echocardiography . Am J Cardiol. 53:1984;1087-1094.
32. Wasserman K., Hansen J.E., Sue D.Y., Whipp B.J. Principles of Exercise Testing and Interpretation. 1987;Lea & Fabiger, Philadelphia.
33. Maron B.J., Gottdiener J.S., Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy a wide angle, two-dimensional echocardiographic study of 125 patients . Am J Cardiol. 48:1981;418-428.
34. Klues H.G., Schiffers A., Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients . J Am Coll Cardiol. 26:1995;1699-1708.
35. Panza J.A., Petrone R.K., Fananapazir L., Maron B.J. Utility of continuous wave Doppler in noninvasive assessment of the left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 19:1992;91-99.
36. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
37. Cox D.R. Regression models and life tables. J R Stat Soc B. 34:1972;187-220.
38. Dubach P., Froelicher V.F., Klein J., Oakes D., Grover-McKay M., Friis R. Exercise-induced hypotension in a male population. Criteria, causes and prognosis. Circulation. 78:1988;1380-1387.
39. Hammermeister K.E., DeRouen T.A., Dodge H.T., Zia M. Prognostic and predictive value of exertional hypotension in suspected coronary artery disease. Am J Cardiol. 51:1983;1261-1265.
40. Weiner D.A., McCabe C.H., Cutler S.S., Ryan T.J. Decrease in systolic blood pressure during exercise testing reproducibility, response to coronary bypass surgery and prognostic significance . Am J Cardiol. 49:1982;1627-1631.
41. San Marco M.E., Pontius S., Selvester R.H. Abnormal blood pressure response and marked ischemic ST depression as predictors of severe coronary artery disease. Circulation. 61:(Suppl III):1980;III-572-III-578.